pyrimidin-2-one beta-ribofuranoside has been researched along with Cell Transformation, Neoplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkamal, I; Fuller, TF; Ikromov, O; Kempkensteffen, C; Krause, H; Magheli, A; Miller, K; Tölle, A | 1 |
| Issa, JP | 1 |
| Desco, M; Esteller, M; Flores, JM; Fraga, MF; Herranz, M; Marquez, V; Martín-Caballero, J; Ruiz-Cabello, J | 1 |
3 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytidine; DNA Modification Methylases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Metallothionein; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic | 2015 |
Cancer prevention: epigenetics steps up to the plate.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Chemoprevention; Cytidine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Models, Biological; Neoplasms | 2008 |
The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Cytidine; DNA Methylation; Drug Evaluation, Preclinical; Gene Silencing; Injections, Intraperitoneal; Lymphoma, T-Cell; Mice; Neoplasms, Experimental | 2006 |